FDA.reportPublic FDA data

benzocaine 0.2 MG/MG Oral Paste [Orajel]

RxCUI
1053239
RxNorm name
benzocaine 0.2 MG/MG Oral Paste [Orajel]
Display name
ORAJEL (Oral Paste)
Full name
benzocaine 0.2 MG/MG Oral Paste [Orajel]
Term type
SBD
Status
Active
Strength
20%
Dose form
Paste
Route
Oral Paste
Updated
2026-06-05 07:08:22

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022011
Active start
022011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzocaine0.2 MG / 1 MGbenzocainebenzocaine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Paste346171

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STROrajel 0.2 MG/MG Oral PasteNAMES
RxNorm Namebenzocaine 0.2 MG/MG Oral Paste [Orajel]NAMES
RxNorm SynonymOrajel 0.2 MG/MG Oral PasteNAMES
RxNorm SynonymOrajel Maximum Strength 20 % Mucous Membrane PasteNAMES
TTYSBDATTRIBUTES
RxCUI1053239CODES
MMSL_CODEBD6190CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
10310039201rxnav_ndcsyes
10310039202rxnav_historical

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.2 MG/MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD6190
CODESRxCUI1053239
NAMESPrescribable SynonymOrajel Maximum Strength PM 20 % Oral Paste
NAMESRXNAV_STROrajel 0.2 MG/MG Oral Paste
NAMESRxNorm Namebenzocaine 0.2 MG/MG Oral Paste [Orajel]
NAMESRxNorm SynonymOrajel 0.2 MG/MG Oral Paste
NAMESRxNorm SynonymOrajel Maximum Strength 20 % Mucous Membrane Paste
SOURCESSourceGold Standard Alchemy
SOURCESSourceMultum MediSource Lexicon